Please login to the form below

Not currently logged in
Email:
Password:

Sanofi to supply flu vaccine to Brazil

Sanofi Pasteur has signed an agreement for the production and supply of a vaccine against the novel A (H1N1) influenza virus

Sanofi Pasteur, the vaccines division of sanofi-aventis, has signed an agreement with Butantan Institute in Brazil for the production and supply of a vaccine against the novel A(H1N1) influenza virus. 

The Brazilian Ministry of Health has ordered an initial supply of 18 million doses of the new A(H1N1) influenza virus vaccine, comprising one million doses in final presentation and 17 million doses in bulk form. The agreement includes an option for an additional 15 million doses of A(H1N1) vaccine, should the World Health Organisation (WHO) request influenza manufacturers to switch production from the regular Southern Hemisphere Seasonal influenza vaccine to the Pandemic A(H1N1) vaccine. 

Wayne Pisano, Sanofi Pasteur's president and chief executive officer, said: "Sanofi Pasteur and Butantan Institute are historical and successful partners who will bring a tailored response to public health needs in the context of pandemic influenza in Brazil. Our goal is to produce and deliver as quickly as possible the pandemic vaccine, which meets the requirements defined by the Brazilian health authorities. We rely on our close collaboration with Butantan Institute to produce and deliver the vaccine."  

The A(H1N1) vaccine antigen bulk will be manufactured in Sanofi Pasteur's facility. Dosage requirements will be determined by clinical trial outcomes. Butantan Institute will make up the A(H1N1) vaccine's final formulation, filling and packaging in its Sao Paolo facility (Brazil). It will also handle distribution. 

Sanofi Pasteur is a leading vaccine manufacturer in Brazil with a portfolio of 20 vaccines. Its involvement in the country dates back to 1974 when it produced and delivered 90 million doses of meningitis vaccine in response to an outbreak of the disease. Since 1999, Sanofi Pasteur has partnered Butantan Institute in the immunisation of Brazil's elderly population against influenza. In 2008, Sanofi Pasteur responded to a yellow fever outbreak in Brazil by delivering four million doses of yellow fever vaccine.

9th September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics